| MBL2 combined genotypes | Control (number = 118) n (%) | Patients (number = 127) n (%) | P1 | Patient with Gram-negative infection (number = 86) n (%) | Patient with Gram-positive infection (number = 41) n (%) | P2 |
| High producer |
|
|
|
|
|
|
| YA\YA |
|
|
|
|
|
|
| HYA\HYA | 10 (8.4) | 9 (7.1) | 0.8 | 4 (4.7) | 5 (12.2) | 0.1 |
| LYA\LYA | 8 (6.8) | 9 (7.1) | 1 | 6 (7) | 3 (7.3) | 1 |
| HYA\LYA | 31 (26.3) | 25 (19.7) | 0.2 | 15 (17.4) | 10 (24.3) | 0.5 |
| YA\XA |
|
|
|
|
|
|
| LYA\LXA | 4 (3.4) | 3 (2.4) | 0.7 | 3 (3.5) | 0 | 0.6 |
| HYA\LXA | 10 (8.5) | 9 (7.1) | 0.8 | 5 (5.8) | 4 (9.7) | o.5 |
| Medium producer |
|
|
|
|
|
|
| XA\XA |
|
|
|
|
|
|
| LXA\LXA | 4 (3.4) | 5 (3.9) | 1 | 5 (5.8) | 0 | 0.2 |
| YA\O |
|
|
|
|
|
|
| HYA\HYD | 2 (1.7) | 3 (2.4) | 1 | 3 (3.5) | 0 | 0.6 |
| HYA\LYB | 16 (13.6) | 23 (18.1) | 0.3 | 13 (15.1) | 10 (24.4) | 0.3 |
| HYA\LYC | 0 | 1 (0.8) | 1 | 1 (1.2) | 0 | 1 |
| LYA\HYD | 3 (2.5) | 1 (0.8) | 0.4 | 0 | 1 (2.4) | 1 |
| LYA\LYB | 12 (10.2) | 7 (5.5) | 0.2 | 7 (8.1) | 0 | 0.9 |
| Low producer |
|
|
|
|
|
|
| XA\O |
|
|
|
|
|
|
| LXA\LYB | 6 (5.1) | 10 (7.9) | 0.4 | 5 (5.8) | 5 (12.2) | 0.3 |
| LXA\HYD | 4 (3.4) | 8 (6.3) | 0.4 | 6 (7) | 2 (4.9) | 1 |
| O\O |
|
|
|
|
|
|
| LYB\LYB | 4 (3.4) | 10 (7.9) | 0.2 | 9 (10.5) | 1 (2.4) | 0.2 |
| LYB\HYD | 4 (3.4) | 3 (2.4) | 0.7 | 3 (3.5) | - | 0.6 |
| HYD\HYD | 0 | 1 (0.8) | 1 | 1 (1.2) | - | 1 |